NCT02924402 2024-11-13Study to Evaluate Safety and Tolerability of XmAb13676 (Plamotamab) in Patients With CD20-expressing Hematologic MalignanciesXencor, Inc.Phase 1 Completed154 enrolled
NCT03434262 2024-05-31SJDAWN: St. Jude Children's Research Hospital Phase 1 Study Evaluating Molecularly-Driven Doublet Therapies for Children and Young Adults With Recurrent Brain TumorsSt. Jude Children's Research HospitalPhase 1 Completed68 enrolled